Please upgrade to premimum
subscription to use this feature.
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has. . . ....
Be the first one to post.